Introducing legislation on prescription drug prices
What they say
His campaign says he has introduced legislation to lower the cost of prescription drugs.
“introduced legislation to lower the cost of prescription drugs”
Source: Vicente Gonzalez for Congress
What the record shows ·
The official text of the Drug Price Transparency in Medicaid Act names him among those who introduced it, twice. H.R. 6101 of December 1, 2021 reads "Mr. Carter of Georgia (for himself and Mr. Vicente Gonzalez of Texas) introduced the following bill", and H.R. 1613 of March 17, 2023 names him first after Carter; Congress.gov lists Carter as sponsor and Gonzalez as an original cosponsor of both. The bill curbs spread pricing by pharmacy benefit managers in Medicaid, and that provision passed the House as section 202 of the Lower Costs, More Transparency Act on December 11, 2023, 320-71, with his Yea (Roll Call 708). In 2025 he was an original cosponsor of the PBM Reform Act (H.R. 4317) and both Pharmacists Fight Back bills (H.R. 6609 and 6610). Three of the PBM Reform Act's six sections, on Medicare drug plans and employer health plans, became law almost word for word as sections 6223, 6224 and 6701 of the Consolidated Appropriations Act, 2026 (Public Law 119-75). He voted Yea when the House passed that act on January 22, 2026 (Roll Call 45) and Nay on the final House vote on February 3 (Roll Call 53). In all he has cosponsored more than twenty drug-price bills, among them the Elijah E. Cummings Lower Drug Costs Now Act in 2019, and voted for the Inflation Reduction Act, whose Medicare drug-price negotiation became law in 2022.
Sources: U.S. Government Publishing Office, U.S. Government Publishing Office, U.S. Government Publishing Office, Office of the Clerk, U.S. House of Representatives, Congress.gov, U.S. Government Publishing Office, Office of the Clerk, U.S. House of Representatives, Office of the Clerk, U.S. House of Representatives, Congress.gov, Congress.gov, Office of the Clerk, U.S. House of Representatives, U.S. Government Publishing Office, Congress.gov, Congress.gov
Limit: The bill text uses his verb: it names him among the members who introduced the bill, though Carter was its sponsor and Gonzalez the lead cosponsor. None of the 55 items Congress.gov lists him as sponsoring concerns drug prices. The bill is aimed at what Medicaid pays for drugs, not at the price a patient pays. The Medicaid bill did not become law, and its spread-pricing section is not in the 2025 reconciliation act or the 2026 appropriations act. That act did carry most of the PBM Reform Act, though he voted against its final version.